Physician Wealth Advisors
ROIV icon

Physician Wealth Advisors’s Roivant Sciences ROIV Stock Holding History

Physician Wealth Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.06K Buy
29
+12
+71% +$435 ﹤0.01% 1910
2026
Q2 		$602 Buy
+17
New +$502 ﹤0.01% 2022

Other funds holding ROIV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Penn Davis McFarland
Penn Davis McFarland Dallas, Texas $1.17B AUM 26.22% 1-Year Est. Return
Parkside Financial Bank & Trust
Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Cache Advisors
Cache Advisors San Francisco, California $1.63B AUM 33.42% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
Signature Estate & Investment Advisors
Signature Estate & Investment Advisors Los Angeles, California $5.67B AUM 20.02% 1-Year Est. Return

Physician Wealth Advisors's ROIV Position: Q3 2026 in Review

Physician Wealth Advisors increased its Roivant Sciences (ROIV) stake by 71% in Q3 2026, buying an estimated $435 and bringing the position to 29 shares worth $1.06K. The position accounts for ﹤0.01% of the portfolio, ranked #1910.

Physician Wealth Advisors first reported a position in ROIV in Q2 2026 and has held it in 2 quarters since. 122 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Physician Wealth Advisors held 29 shares of Roivant Sciences worth $1.06K as of Q3 2026.
  • Physician Wealth Advisors bought 12 Roivant Sciences shares in Q3 2026, an estimated $435.
  • Roivant Sciences made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #1910 holding.
  • Physician Wealth Advisors first reported a position in Roivant Sciences in Q2 2026 and has held it in 2 quarters since.
  • 122 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.